The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Comprehensive research report: pcif1 / CAPAM (PCIF1) in Danio rerio (UniProt A0A0R4IKJ1)

Executive summary (identity verified)

The UniProt target A0A0R4IKJ1 corresponds to Danio rerio pcif1, annotated as mRNA (2′-O-methyladenosine-N(6)-)-methyltransferase (cap-specific adenosine methyltransferase; CAPAM/PCIF1), EC 2.1.1.62. Primary literature identifying CAPAM/PCIF1 as the cap-adjacent N6 methyltransferase explicitly includes zebrafish CAPAM (zCAPAM) in structural work, supporting that zebrafish pcif1 is the vertebrate ortholog of mammalian PCIF1/CAPAM and is expected to catalyze cap m6Am formation. (akichika2019capspecificterminaln6methylation pages 2-3, oerum2021acomprehensivereview pages 7-8, sendinc2019pcif1catalyzesm6am pages 1-3)

A limitation of the current evidence set is that it contains little zebrafish-specific functional genetics (phenotypes, developmental roles, expression maps, or direct localization assays). Thus, zebrafish pcif1 functional annotation below is based on (i) direct zebrafish structural evidence and detection of m6Am in zebrafish mRNA, plus (ii) high-confidence orthology inference from vertebrate PCIF1/CAPAM biochemistry. (akichika2019capspecificterminaln6methylation pages 2-3, oerum2021acomprehensivereview pages 7-8, sendinc2019pcif1catalyzesm6am pages 1-3)

1) Key concepts and definitions (current understanding)

1.1 The mRNA 5′ cap and cap-adjacent methylation

Eukaryotic mRNAs possess a 5′ m7G cap (7-methylguanosine) linked to the first transcribed nucleotide, which in vertebrates can be 2′-O-methylated (Nm). When the first nucleotide is 2′-O-methyladenosine (Am), it can be further methylated at the N6 position to generate N6,2′-O-dimethyladenosine (m6Am) at the cap-adjacent position. CAPAM/PCIF1 is the cap-specific methyltransferase that writes this m6Am mark at the transcription start nucleotide. (akichika2019capspecificterminaln6methylation pages 2-3, oerum2021acomprehensivereview pages 7-8)

1.2 CAPAM/PCIF1 (Phosphorylated CTD-interacting factor 1)

CAPAM/PCIF1 is a SAM-dependent N6-adenosine methyltransferase that installs m6Am at the cap-adjacent nucleotide of mRNAs. It is described as the unique/only methyltransferase responsible for cap-adjacent m6Am on vertebrate mRNAs in the reviewed literature. (akichika2019capspecificterminaln6methylation pages 2-3, wu2023pcif1theonly pages 2-4, jin2024regulationofm6am pages 1-2)

1.3 Relation to broader epitranscriptomics (m6A vs m6Am)

The m6Am mark is distinct from internal m6A. PCIF1 is described as acting on 5′ terminal, capped substrates, and not depositing internal m6A marks on mRNA bodies in the key primary work and structural reviews. (oerum2021acomprehensivereview pages 7-8, sendinc2019pcif1catalyzesm6am pages 1-3)

2) Verified molecular function of zebrafish pcif1/CAPAM

2.1 Enzymatic reaction and cofactor

Reaction (writer activity): methylation of the N6 position of cap-adjacent adenosine/Am, producing m6A or m6Am, with S-adenosylmethionine (SAM) as methyl donor and SAH as product. In vertebrate capped mRNA contexts, the key physiological substrate is cap-adjacent Am, yielding m6Am. (akichika2019capspecificterminaln6methylation pages 2-3, jin2024regulationofm6am pages 1-2)

Canonical substrate/product example:
- m7GpppAm → m7Gpppm6Am (cap-dependent, early-transcript position). (akichika2019capspecificterminaln6methylation pages 2-3, wu2023pcif1theonly pages 2-4)

2.2 Substrate specificity and quantitative kinetics (primary data)

CAPAM/PCIF1 displays strong cap dependence and a strong preference for 2′-O-methylated adenosine at the cap-adjacent position.

In the primary biochemical characterization, CAPAM shows markedly different affinity for two capped substrates:
- Km ≈ 3.5 μM for m7GpppAm
- Km ≈ 28 μM for m7GpppA
indicating substantially higher affinity for the 2′-O-methylated cap-adjacent adenosine. (akichika2019capspecificterminaln6methylation pages 2-3)

Additional specificity features reported:
- The m7G cap is required for efficient N6 methylation; non-m7G-capped substrates (e.g., GpppA or pppA) show little activity. (akichika2019capspecificterminaln6methylation pages 2-3)
- CAPAM prefers longer RNA substrates; ~6 nt is described as the minimum effective length, with low activity on shorter oligos. (akichika2019capspecificterminaln6methylation pages 2-3)
- CAPAM does not methylate internal Am and acts specifically at the 5′ cap-adjacent position in the reviewed structural literature. (oerum2021acomprehensivereview pages 7-8)

These biochemical properties are directly relevant to zebrafish pcif1 because the discovery paper reports that zebrafish CAPAM shares conserved motifs/structural features and was used in structure determination, supporting conservation of substrate-recognition determinants in the zebrafish ortholog. (akichika2019capspecificterminaln6methylation pages 2-3, oerum2021acomprehensivereview pages 7-8)

2.3 Structural basis of catalysis (zebrafish-relevant, with figure evidence)

CAPAM has a core methyltransferase domain and a helical domain that together form binding surfaces for the cap and RNA. The structure (with cap analog and SAH) reveals the cap-binding pocket and the SAM/SAH active-site region, supporting a mechanism for cap-specific terminal N6 methylation. (akichika2019capspecificterminaln6methylation pages 2-3, akichika2019capspecificterminaln6methylation media ccc03861, akichika2019capspecificterminaln6methylation media 065abfbf)

The structural review explicitly notes that zebrafish CAPAM structures have been solved (e.g., PDB 6IRX and ligand-containing PDB 6IS0), further supporting that zebrafish pcif1 is structurally characterized within this enzyme family. (oerum2021acomprehensivereview pages 7-8)

3) Domain architecture and protein interactions (functional annotation)

3.1 Domain organization

Across vertebrates, CAPAM/PCIF1 is described as having:
- an N-terminal WW domain
- a helical domain that contributes to cap/RNA recognition
- a C-terminal methyltransferase (Rossmann-like) domain with a conserved catalytic NPPF motif critical for activity. (akichika2019capspecificterminaln6methylation pages 2-3, wu2023pcif1theonly pages 2-4, oerum2021acomprehensivereview pages 7-8, jin2024regulationofm6am pages 1-2)

Catalytic importance of the NPPF region is emphasized, with mutational evidence (reported in reviews of the primary data) that disrupting this conserved motif abrogates methyltransferase activity. (wu2023pcif1theonly pages 2-4, jin2024regulationofm6am pages 1-2)

3.2 RNA polymerase II CTD binding and co-transcriptional recruitment

A key mechanistic feature of PCIF1 is that its WW domain binds the Ser5-phosphorylated C-terminal domain (CTD) of RNA polymerase II, consistent with recruitment to early transcription complexes and co-transcriptional installation of m6Am at transcription start sites. (akichika2019capspecificterminaln6methylation pages 2-3, wu2023pcif1theonly pages 2-4, jin2024regulationofm6am pages 1-2)

The 2019 Science study reports WW-domain interaction with Ser5-phosphorylated RNAPII CTD and co-immunoprecipitation with Ser5-phosphorylated RNAPII, supporting this coupling between transcription and cap-proximal methylation. (akichika2019capspecificterminaln6methylation pages 2-3)

4) Subcellular localization and site of action

4.1 Nuclear, transcription-coupled role (best-supported model)

PCIF1 is described as primarily nuclear and associated with transcription machinery/chromatin in reviewed summaries of the primary literature, consistent with its RNAPII CTD interaction and the concept that m6Am is added to nascent mRNA early during elongation. (akichika2019capspecificterminaln6methylation pages 2-3, wu2023pcif1theonly pages 2-4)

4.2 Zebrafish-specific localization: evidence gaps

No zebrafish-specific imaging or biochemical fractionation data establishing pcif1 subcellular localization were retrieved in the current evidence set; thus, nuclear localization for zebrafish pcif1 should be treated as orthology-based inference supported by conservation of WW domain function and zebrafish structural conservation rather than as directly measured in zebrafish tissues/cells here. (akichika2019capspecificterminaln6methylation pages 2-3, oerum2021acomprehensivereview pages 7-8)

5) Zebrafish-specific evidence and conservation/orthology

5.1 Direct zebrafish evidence present in primary literature

Two lines of zebrafish-specific evidence were identified:
1. Zebrafish CAPAM (zCAPAM) was used alongside human CAPAM for crystallographic structure determination, and conserved motifs/domains are discussed as shared across animals, supporting zebrafish orthology. (akichika2019capspecificterminaln6methylation pages 2-3, oerum2021acomprehensivereview pages 7-8)
2. m6Am is detectable in zebrafish mRNA (measurement via approaches that require decapping prior to LC-MS/MS is described in the key primary literature). (sendinc2019pcif1catalyzesm6am pages 1-3)

5.2 Evolutionary scope (expert synthesis)

Structural review discussion indicates CAPAM homologs are found in higher organisms but not in yeast/worm, aligning with the observation that m6Am is a vertebrate cap-associated modification and supporting the view that zebrafish pcif1 is part of a vertebrate-conserved pathway. (oerum2021acomprehensivereview pages 7-8)

6) Recent developments (prioritizing 2023–2024)

6.1 2023 review synthesis: PCIF1 as unique m6Am writer and disease relevance

A 2023 review summarizes PCIF1 as the unique m6Am methyltransferase, reiterating cap dependence and the model of nuclear/cotranscriptional action, and highlights expanding connections between PCIF1/m6Am biology and disease contexts (notably cancers and other conditions). While disease associations are largely mammalian, they frame current research directions and the importance of PCIF1 as a regulatory node in gene expression. (Publication: Oct 2023; URL: https://doi.org/10.1186/s12935-023-03066-7) (wu2023pcif1theonly pages 2-4, wu2023pcif1theonly pages 1-2)

A statistic frequently cited in this review-level literature is that ~30% of cellular mRNAs harbor m6Am at the first nucleotide (cap-adjacent), emphasizing potential transcriptome-wide impact. (wu2023pcif1theonly pages 1-2)

6.2 2024 authoritative review: regulators of m6Am (writers/erasers) and functions

A 2024 review emphasizes m6Am as a dynamic, reversible modification regulated by writers (including PCIF1) and an eraser (FTO), and summarizes evidence for m6Am impacts on splicing, stability, and translation in different biological contexts. (Publication: Mar 2024; URL: https://doi.org/10.1093/jmcb/mjae012) (jin2024regulationofm6am pages 1-2)

The review also reiterates a mechanistic framework where PCIF1 interaction with Ser5-phosphorylated RNAPII CTD enables deposition at transcription start sites during transcriptional elongation. (jin2024regulationofm6am pages 1-2)

7) Current applications and real-world implementations

7.1 Practical assay implementations used in the field

Key real-world implementations for CAPAM/PCIF1 and m6Am biology include:
- RNA-MS / LC–MS/MS approaches that quantify cap-adjacent modifications (often requiring decapping) to distinguish m6Am from other nucleosides. (akichika2019capspecificterminaln6methylation pages 2-3, sendinc2019pcif1catalyzesm6am pages 1-3)
- In vitro methyltransferase assays with synthetic capped RNAs to measure substrate preferences and kinetics (e.g., Km differences for m7GpppAm vs m7GpppA). (akichika2019capspecificterminaln6methylation pages 2-3)
- Structural biology (crystallography) to resolve cap-binding and catalytic-site features, including structures solved with zebrafish CAPAM constructs. (akichika2019capspecificterminaln6methylation pages 2-3, oerum2021acomprehensivereview pages 7-8, akichika2019capspecificterminaln6methylation media ccc03861)

These approaches are directly portable to zebrafish systems (e.g., using zebrafish cell lines, embryos, or tissues), and the existence of zebrafish structural models supports rational experimental design in DANRE. (oerum2021acomprehensivereview pages 7-8)

7.2 Translational relevance (mostly mammalian contexts)

Although not zebrafish-specific, recent literature highlights PCIF1 as a target/biomarker candidate in disease-focused contexts (cancer/viral infection), motivating broader interest in CAPAM/PCIF1. These applications provide a rationale for studying conserved vertebrate biology in zebrafish models. (wu2023pcif1theonly pages 2-4, jin2024regulationofm6am pages 1-2)

8) Expert opinions and analysis (authoritative synthesis)

8.1 Where PCIF1 acts in gene expression pathways

The most strongly supported mechanistic model positions PCIF1 at the interface of transcription initiation/early elongation and mRNA cap maturation, via WW-domain binding to Ser5-phosphorylated RNAPII CTD and cap-structure recognition that restricts methylation to the cap-proximal site. This is a clear biochemical pathway: RNAPII CTD phosphorylation state provides spatial/temporal recruitment control, and the m7G cap plus 2′-O-methylation provides substrate selectivity. (akichika2019capspecificterminaln6methylation pages 2-3, oerum2021acomprehensivereview pages 7-8, jin2024regulationofm6am pages 1-2)

8.2 Expected zebrafish function (inference with explicit uncertainty)

Given (i) direct zebrafish structural characterization within the 2019 discovery paper and (ii) detection of m6Am in zebrafish mRNA, zebrafish pcif1 (UniProt A0A0R4IKJ1) is best annotated as the cap-specific m6Am writer for zebrafish mRNAs, operating in the nucleus and likely acting co-transcriptionally. However, zebrafish-specific genetic/phenotypic validation was not found in the current evidence set and remains an open gap for DANRE functional annotation beyond the conserved molecular function. (akichika2019capspecificterminaln6methylation pages 2-3, oerum2021acomprehensivereview pages 7-8, sendinc2019pcif1catalyzesm6am pages 1-3)

9) Key statistics and data points (from cited studies)

• Enzyme kinetics (substrate preference): Km 3.5 μM for m7GpppAm vs 28 μM for m7GpppA (cap-adjacent 2′-O-methylation strongly enhances affinity). (akichika2019capspecificterminaln6methylation pages 2-3)
• Transcriptome prevalence: m6Am is reported to occur on ~30% of cellular mRNAs when the first transcribed nucleotide is adenosine/Am (review-level estimate). (wu2023pcif1theonly pages 1-2)

Visual evidence (structure)

The following figure panels from the 2019 Science paper illustrate CAPAM/PCIF1 bound to a cap analog and SAH, including the cap-binding pocket and active-site region; these structural data underpin mechanistic understanding and are directly relevant because zebrafish CAPAM constructs were used in the structural work. (akichika2019capspecificterminaln6methylation media ccc03861, akichika2019capspecificterminaln6methylation media 065abfbf)

Summary table (functional annotation)

Table: This table summarizes the best-supported functional annotation for Danio rerio pcif1/CAPAM, emphasizing experimentally established PCIF1/CAPAM biochemistry and clearly separating zebrafish-specific evidence from orthology-based inference.

References (with URLs and publication dates)

• Akichika S. et al. “Cap-specific terminal N6-methylation of RNA by an RNA polymerase II–associated methyltransferase.” Science (Jan 2019). https://doi.org/10.1126/science.aav0080 (akichika2019capspecificterminaln6methylation pages 2-3)
• Sendinc E. et al. “PCIF1 Catalyzes m6Am mRNA Methylation to Regulate Gene Expression.” Molecular Cell (Aug 2019). https://doi.org/10.1016/j.molcel.2019.05.030 (sendinc2019pcif1catalyzesm6am pages 1-3)
• Oerum S. et al. “A comprehensive review of m6A/m6Am RNA methyltransferase structures.” Nucleic Acids Research (May 2021). https://doi.org/10.1093/nar/gkab378 (oerum2021acomprehensivereview pages 7-8)
• Wu Y. et al. “PCIF1, the only methyltransferase of N6,2-O-dimethyladenosine.” Cancer Cell International (Oct 2023). https://doi.org/10.1186/s12935-023-03066-7 (wu2023pcif1theonly pages 2-4, wu2023pcif1theonly pages 1-2)
• Jin H. et al. “Regulation of m6Am RNA modification and its implications in human diseases.” Journal of Molecular Cell Biology (Mar 2024). https://doi.org/10.1093/jmcb/mjae012 (jin2024regulationofm6am pages 1-2)

References

1. (akichika2019capspecificterminaln6methylation pages 2-3): Shinichiro Akichika, Seiichi Hirano, Yuichi Shichino, Takeo Suzuki, Hiroshi Nishimasu, Ryuichiro Ishitani, Ai Sugita, Yutaka Hirose, Shintaro Iwasaki, Osamu Nureki, and Tsutomu Suzuki. Cap-specific terminal n6-methylation of rna by an rna polymerase ii–associated methyltransferase. Science, Jan 2019. URL: https://doi.org/10.1126/science.aav0080, doi:10.1126/science.aav0080. This article has 419 citations and is from a highest quality peer-reviewed journal.

2. (oerum2021acomprehensivereview pages 7-8): Stephanie Oerum, Vincent Meynier, Marjorie Catala, and Carine Tisné. A comprehensive review of m6a/m6am rna methyltransferase structures. Nucleic Acids Research, 49:7239-7255, May 2021. URL: https://doi.org/10.1093/nar/gkab378, doi:10.1093/nar/gkab378. This article has 560 citations and is from a highest quality peer-reviewed journal.

3. (sendinc2019pcif1catalyzesm6am pages 1-3): Erdem Sendinc, David Valle-Garcia, Abhinav Dhall, Hao Chen, Telmo Henriques, Jose Navarrete-Perea, Wanqiang Sheng, Steven P. Gygi, Karen Adelman, and Yang Shi. Pcif1 catalyzes m6am mrna methylation to regulate gene expression. Molecular Cell, 75:620-630.e9, Aug 2019. URL: https://doi.org/10.1016/j.molcel.2019.05.030, doi:10.1016/j.molcel.2019.05.030. This article has 320 citations and is from a highest quality peer-reviewed journal.

4. (wu2023pcif1theonly pages 2-4): Yuting Wu, Xianming Pu, Sihui Wu, Yiran Zhang, Shengqiao Fu, Haowen Tang, Xu Wang, and Min Xu. Pcif1, the only methyltransferase of n6,2-o-dimethyladenosine. Cancer Cell International, Oct 2023. URL: https://doi.org/10.1186/s12935-023-03066-7, doi:10.1186/s12935-023-03066-7. This article has 18 citations and is from a peer-reviewed journal.

5. (jin2024regulationofm6am pages 1-2): Hao Jin, Zhouyuanjing Shi, Tianhua Zhou, and Shanshan Xie. Regulation of m6am rna modification and its implications in human diseases. Journal of Molecular Cell Biology, Mar 2024. URL: https://doi.org/10.1093/jmcb/mjae012, doi:10.1093/jmcb/mjae012. This article has 16 citations and is from a peer-reviewed journal.

6. (akichika2019capspecificterminaln6methylation media ccc03861): Shinichiro Akichika, Seiichi Hirano, Yuichi Shichino, Takeo Suzuki, Hiroshi Nishimasu, Ryuichiro Ishitani, Ai Sugita, Yutaka Hirose, Shintaro Iwasaki, Osamu Nureki, and Tsutomu Suzuki. Cap-specific terminal n6-methylation of rna by an rna polymerase ii–associated methyltransferase. Science, Jan 2019. URL: https://doi.org/10.1126/science.aav0080, doi:10.1126/science.aav0080. This article has 419 citations and is from a highest quality peer-reviewed journal.

7. (akichika2019capspecificterminaln6methylation media 065abfbf): Shinichiro Akichika, Seiichi Hirano, Yuichi Shichino, Takeo Suzuki, Hiroshi Nishimasu, Ryuichiro Ishitani, Ai Sugita, Yutaka Hirose, Shintaro Iwasaki, Osamu Nureki, and Tsutomu Suzuki. Cap-specific terminal n6-methylation of rna by an rna polymerase ii–associated methyltransferase. Science, Jan 2019. URL: https://doi.org/10.1126/science.aav0080, doi:10.1126/science.aav0080. This article has 419 citations and is from a highest quality peer-reviewed journal.

8. (wu2023pcif1theonly pages 1-2): Yuting Wu, Xianming Pu, Sihui Wu, Yiran Zhang, Shengqiao Fu, Haowen Tang, Xu Wang, and Min Xu. Pcif1, the only methyltransferase of n6,2-o-dimethyladenosine. Cancer Cell International, Oct 2023. URL: https://doi.org/10.1186/s12935-023-03066-7, doi:10.1186/s12935-023-03066-7. This article has 18 citations and is from a peer-reviewed journal.

9. (zeng2025capspecificterminaln6methyladeonsine pages 2-4): Hui Zeng, Yidong Wu, and Xinghua Long. Cap-specific terminal n6-methyladeonsine methylation of rna mediated by pcif1 and possible therapeutic implications. Jan 2025. URL: https://doi.org/10.1016/j.gendis.2023.101181, doi:10.1016/j.gendis.2023.101181. This article has 3 citations.

10. (pandey2020themammaliancapspecific pages 1-4): Radha Raman Pandey, Elena Delfino, David Homolka, Adriana Roithova, Kuan-Ming Chen, Lingyun Li, Giulia Franco, Cathrine Broberg Vågbø, Emmanuel Taillebourg, Marie-Odile Fauvarque, and Ramesh S. Pillai. The mammalian cap-specific m6am rna methyltransferase pcif1 regulates transcript levels in mouse tissues. Cell reports, 32 7:108038, Aug 2020. URL: https://doi.org/10.1016/j.celrep.2020.108038, doi:10.1016/j.celrep.2020.108038. This article has 88 citations and is from a highest quality peer-reviewed journal.

Artifacts

• Edison artifact artifact-00
  

Citations

1. oerum2021acomprehensivereview pages 7-8
2. pandey2020themammaliancapspecific pages 1-4
3. https://doi.org/10.1186/s12935-023-03066-7
4. https://doi.org/10.1093/jmcb/mjae012
5. https://doi.org/10.1126/science.aav0080;
6. https://doi.org/10.1016/j.molcel.2019.05.030;
7. https://doi.org/10.1186/s12935-023-03066-7;
8. https://doi.org/10.1093/nar/gkab378;
9. https://doi.org/10.1016/j.celrep.2020.108038
10. https://doi.org/10.1093/nar/gkab378
11. https://doi.org/10.1073/pnas.2210361120
12. https://doi.org/10.1126/science.aav0080
13. https://doi.org/10.1016/j.molcel.2019.05.030
14. https://doi.org/10.1126/science.aav0080,
15. https://doi.org/10.1093/nar/gkab378,
16. https://doi.org/10.1016/j.molcel.2019.05.030,
17. https://doi.org/10.1186/s12935-023-03066-7,
18. https://doi.org/10.1093/jmcb/mjae012,
19. https://doi.org/10.1016/j.gendis.2023.101181,
20. https://doi.org/10.1016/j.celrep.2020.108038,